Topic: Health and Medicine
Dr. Moira Gunn speaks with Dr. Nancy Mize about the challenges of submitting drug applications worldwide, and the new technology agreement which will hopefully make it easier. And on the Bio-Issue of the Week, David Ewing Duncan talks about new hopes for old anti-biotics.
Dr. Moira Gunn revisits the undeniable fate of the presidential stem cell line. On the Bio-Issue of the Week, David Ewing Duncan talks about his trip to the British BioBank.
Dr. Moira Gunn and David Ewing Duncan speak with Ian Wilmut, Professor of Reproductive Science, University of Edinburgh & Director, Scottish Centre for Regenerative Medicine. They ask him about the progress which has been made since his team cloned Dolly.
According to the FDA there are over 75 million diabetics and pre-diabetics in the United States - 30 million of whom are unaware of their condition. Dr. Moira Gunn speaks with VeraLight CEO David van Avermaete about a new technology which can warn people they are pre-diabetic.
Dr. Moira Gunn speaks with George Scangos, the President and CEO at Exelixis. They discuss innovation in drug research and development. On the Bio-Issue of the Week, David Ewing Duncan tries to make sense of science and Hollywood.
Dr. Moira Gunn speaks with Dr. Richard Ho, the Director of Disease Simulation at Johnson & Johnson and Randy Scott, Chairman & CEO at Genomics Health. Ho explains how they are simulating the entire human body on computers. Scott talks about how his company is matching patients' genes to chemotherapy and other treatments.
As part of the BayBIO series on personalized medicine, Dr. Moira Gunn speaks with Jeff Peterson, CEO of Target Discovery, Inc. They discuss measuring tiny isoforms that exist within proteins - a capability that offers much to people suffering from prostate and ovarian cancer.
As part of the BayBIO series on personalized medicine, Dr. Moira Gunn speaks with Pierre Cassignol, President & CEO of XDX Expression Diagnostics. Cassignol talks about a major step forward in the long term treatment of transplant recipients.
Dr. Moira Gunn speaks with UC Business School professor Peter Navarro in the second of a two-part interview on China. This week - the surprising blood scandal which spread HIV and the culture of counterfeit.
David Ewing Duncan and Dr. Moira Gunn speak with Kari Stefansson, the President and CEO of deCODE Genetics. They discuss the relationship between your genes and your environment.
